SK91594A3 - Trisubstituted pyrimido£5,4-d|-pyrimidines for modulation of multidrugs resistence, medicines containing these compouds and method of their preparation - Google Patents

Trisubstituted pyrimido£5,4-d|-pyrimidines for modulation of multidrugs resistence, medicines containing these compouds and method of their preparation Download PDF

Info

Publication number
SK91594A3
SK91594A3 SK915-94A SK91594A SK91594A3 SK 91594 A3 SK91594 A3 SK 91594A3 SK 91594 A SK91594 A SK 91594A SK 91594 A3 SK91594 A3 SK 91594A3
Authority
SK
Slovakia
Prior art keywords
group
pyrimidine
methyl
carbon atoms
pyrimido
Prior art date
Application number
SK915-94A
Other languages
English (en)
Slovak (sk)
Inventor
Armin Heckel
Uwe Bamberger
Annerose Mauz
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of SK91594A3 publication Critical patent/SK91594A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK915-94A 1993-08-02 1994-07-29 Trisubstituted pyrimido£5,4-d|-pyrimidines for modulation of multidrugs resistence, medicines containing these compouds and method of their preparation SK91594A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4325900A DE4325900A1 (de) 1993-08-02 1993-08-02 Trisubstituierte Pyrimido [5,4-d] pyrimidine zur Modulation der Multidrugresistenz, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
SK91594A3 true SK91594A3 (en) 1995-04-12

Family

ID=6494272

Family Applications (1)

Application Number Title Priority Date Filing Date
SK915-94A SK91594A3 (en) 1993-08-02 1994-07-29 Trisubstituted pyrimido£5,4-d|-pyrimidines for modulation of multidrugs resistence, medicines containing these compouds and method of their preparation

Country Status (22)

Country Link
US (1) US5618814A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0645390A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH0789963A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR950005828A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1041091C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU683888B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG98931A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2129179A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ184594A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE4325900A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EE (1) EE9400255A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI943574A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUT70957A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL110509A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO301479B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ264133A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL304512A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RO (1) RO113557B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU94028278A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK91594A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW251286B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA945689B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW414798B (en) * 1994-09-07 2000-12-11 Thomae Gmbh Dr K Pyrimido (5,4-d) pyrimidines, medicaments comprising these compounds, their use and processes for their preparation
DE19608588A1 (de) * 1996-03-06 1997-09-11 Thomae Gmbh Dr K Pyrimido [5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
DE19608653A1 (de) * 1996-03-06 1997-09-11 Thomae Gmbh Dr K Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US6331543B1 (en) 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
USRE37234E1 (en) * 1996-11-01 2001-06-19 Nitromed, Inc. Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
KR101218213B1 (ko) * 2003-07-03 2013-01-04 시토비아 인크. 카스파제의 활성인자 및 세포자멸사의 유도인자로서의4-아릴아미노-퀴나졸린
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
DE102004002557A1 (de) * 2004-01-17 2005-08-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CA2592900A1 (en) 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
CN115650827B (zh) * 2022-10-27 2024-03-15 戊言医药科技(上海)有限公司 用于一类蒽环类毒素衍生物的制备方法、中间体化合物及合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3069211D1 (en) * 1979-07-03 1984-10-25 Thomae Gmbh Dr K 2-(perhydro-1,4-diazino)-pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them
DE2931573A1 (de) * 1979-08-03 1981-02-26 Thomae Gmbh Dr K Mittel zur bekaempfung des wachstums von krebszellen und dessen herstellung
DE3049207A1 (de) * 1980-12-27 1982-07-29 Dr. Karl Thomae Gmbh, 7950 Biberach Neue trisubstituierte pyrimido (5,4-d) pyrimidine, ihre herstellung und ihre verwendung als arzneimittel
DE3423092A1 (de) * 1984-06-22 1986-01-02 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 8-alkylthio-2-piperazino-pyrimido(5,4-d) pyrimidine, ihre herstellung und diese verbindungen enthaltende arzneimittel
DE3833392A1 (de) * 1988-10-01 1990-04-05 Thomae Gmbh Dr K Verwendung von pyrimido(5,4-d)pyrimidinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
JPH0789963A (ja) 1995-04-04
NO301479B1 (no) 1997-11-03
EE9400255A (et) 1996-02-15
CA2129179A1 (en) 1995-02-03
US5618814A (en) 1997-04-08
ZA945689B (en) 1996-02-01
NO942853L (no) 1995-02-03
RU94028278A (ru) 1996-08-27
CN1041091C (zh) 1998-12-09
EP0645390A1 (de) 1995-03-29
IL110509A (en) 1998-01-04
AU6881394A (en) 1995-02-09
PL304512A1 (en) 1995-02-06
TW251286B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1995-07-11
FI943574A0 (fi) 1994-08-01
AU683888B2 (en) 1997-11-27
NO942853D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-08-01
BG98931A (en) 1995-09-29
DE4325900A1 (de) 1995-02-09
NZ264133A (en) 1996-05-28
HU9402253D0 (en) 1994-09-28
IL110509A0 (en) 1994-10-21
RO113557B1 (ro) 1998-08-28
KR950005828A (ko) 1995-03-20
CN1106405A (zh) 1995-08-09
HUT70957A (en) 1995-11-28
CZ184594A3 (en) 1995-02-15
FI943574A7 (fi) 1995-02-03

Similar Documents

Publication Publication Date Title
Cholody et al. Chromophore-modified antineoplastic imidazoacridinones. Synthesis and activity against murine leukemias
US4816586A (en) Delta opioid receptor antagonists
JP4643141B2 (ja) 肥満治療用のmchアンタゴニスト
SK91594A3 (en) Trisubstituted pyrimido£5,4-d|-pyrimidines for modulation of multidrugs resistence, medicines containing these compouds and method of their preparation
CN104903321A (zh) 作为激酶抑制剂的经取代三环苯并咪唑
EP1743886A1 (en) Method of inhibiting neurotrophin-receptor binding
CA2243994A1 (en) 4-amino pyrimidine derivates, medicaments containing these compounds, their use and process for their production
AU2005303893A1 (en) Pyrimidine compounds as histamine modulators
PT87229B (pt) Processo para a preparacao de novas pirazolo{3,4-d}-pirimidinas e de composcoes farmaceuticas que as contem
KR19990087551A (ko) 피리미도[5,4-d]피리미딘, 이를 함유하는 약물, 이의 용도 및이의 제조방법
KR20020089372A (ko) 알파-2 길항제로서의 퀴놀린 유도체
CA3225872A1 (en) Azetidinyl pyrimidines and uses thereof
DE69302829T2 (de) Bicyclische pyrimidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate
Ruchelman et al. Nitro and amino substitution within the A-ring of 5H-8, 9-dimethoxy-5-(2-N, N-dimethylaminoethyl) dibenzo [c, h][1, 6] naphthyridin-6-ones: influence on topoisomerase I-targeting activity and cytotoxicity
CN113307791B (zh) 嘧啶基哌嗪脲类trpv1拮抗/mor激动双靶点化合物及其制备方法和应用
DE69119323T2 (de) Fluoräthylcamptothecinderivate
CA1321996C (en) Condensed diazepinones, processes for preparing them and pharmaceutical compositions containing these compounds
US3301855A (en) Derivatives of 4-nu-(2-nu, nu-dimethylaminolower alkyl)-amino quinazoline
AU612470B2 (en) Novel benzimidazol(1,2-c)quinazolines, their preparation and their use
EP1846401B1 (en) New 4-aminoquinoline derivatives as antimalarials
US3723434A (en) Piperazino isoquinoline bronchodilators
EP3098222B1 (en) Fused acridine derivative and pharmaceutical composition, preparation method and use thereof
CN113816903B (zh) 一种四氢异喹啉二苯乙烯类化合物及其制备方法、应用
HU203347B (en) Process for producing new condensed diazepines and pharmaceutical compositions comprising same
EP1776982A1 (en) Pyrimidine compounds as histamine modulators